Apogee Therapeutics, Inc.
APGE
$68.50
$1.732.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.25% | 0.24% | -25.26% | -37.11% | 31.66% |
| Total Receivables | 26.91% | -6.16% | -- | -- | 286.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 75.51% | 126.95% | 150.36% | 53.96% | 50.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -65.27% | 132.07% | -71.57% | -78.46% | -- |
| Total Current Assets | 39.95% | 1.05% | -24.31% | -36.45% | 32.96% |
|
|
|||||
| Total Current Assets | 39.95% | 1.05% | -24.31% | -36.45% | 32.96% |
| Net Property, Plant & Equipment | 7.89% | 15.76% | 244.55% | 548.53% | 413.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,641.16% | 1,601.17% | 1,792.52% | 1,730.17% | 24.19% |
| Total Assets | 24.30% | -19.34% | -17.85% | -13.29% | 87.83% |
|
|
|||||
| Total Accounts Payable | 14.01% | -83.03% | 2.73% | -43.17% | -50.02% |
| Total Accrued Expenses | -4.43% | 7.50% | 25.51% | 64.76% | 40.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.35% | 42.27% | 139.30% | 248.47% | 193.73% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -2.29% | 4.40% | 28.17% | 52.94% | 38.92% |
|
|
|||||
| Total Current Liabilities | -2.29% | 4.40% | 28.17% | 52.94% | 38.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.83% | -37.73% | 184.05% | 1,144.44% | 821.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -10.51% | -4.93% | 42.02% | 83.94% | 72.90% |
|
|
|||||
| Common Stock & APIC | 43.33% | 11.12% | 8.56% | 7.94% | 103.00% |
| Retained Earnings | -83.63% | -106.27% | -125.30% | -131.78% | -147.16% |
| Treasury Stock & Other | 18.03% | -68.56% | 337.02% | 706.78% | 178.12% |
| Total Common Equity | 26.10% | -20.16% | -19.94% | -15.98% | 88.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.10% | -20.16% | -19.94% | -15.98% | 88.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.10% | -20.16% | -19.94% | -15.98% | 88.67% |
|
|
|||||